Potential of Farnesyl Transferase Inhibitors in Combination Regimens in Squamous Cell Carcinomas
Current therapies for recurrent and metastatic SCC are associated with poor outcomes, and options for later lines of treatment are limited. Insights into potential therapeutic targets, as well as mechanisms of resistance to available therapies, have begun to be elucidated, creating the basis for exp...
Saved in:
Main Authors: | Linda Kessler, Shivani Malik, Mollie Leoni, Francis Burrows |
---|---|
Format: | article |
Language: | EN |
Published: |
MDPI AG
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/788d638e52cd42a7b9d103cf883e0e5b |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
C-Terminal Farnesylation of UCH-L1 Plays a Role in Transport of Epstein-Barr Virus Primary Oncoprotein LMP1 to Exosomes
by: E. Kobayashi, et al.
Published: (2018) -
Bacteria Are New Targets for Inhibitors of Human Farnesyltransferase
by: Lea Weber, et al.
Published: (2021) -
Influence of the glutathione s-transferase gene polymorphisms on the susceptibility to basal cell skin carcinoma
by: Leite,Janaína L, et al.
Published: (2007) -
Modelado de las Relaciones Cuantitativas Estructura-Actividad (QSAR) de Análogos del Tipifarnib con Actividad Antichagásica
by: Granados-Tavera,Kevin, et al.
Published: (2019) -
The role of NEAT1 lncRNA in squamous cell carcinoma of the head and neck is still difficult to define
by: Joanna Kozłowska, et al.
Published: (2020)